Iktos raises 15.5m EUR Series A round to expand its artificial intelligence-based drug discovery technologies and solutions
• The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors.
• Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service.